Pleural effusion is a build-up of excess fluid in the pleural space, which is the thin gap between the lung and the chest wall. Ordinarily, there is a small amount of pleural fluid around the lungs to allow for lubrication. However, an abnormal accumulation of fluid in the pleural space can compress the lung, making breathing more difficult and leading to respiratory symptoms. More importantly, pleural effusion is not a disease in itself. It is a sign that something else is happening in the body, the lungs or the pleura.
A pleural effusion may affect one side of the chest or both. Bilateral pleural effusion often points towards a systemic cause such as congestive heart failure, kidney disease, or liver disease, while a one-sided effusion can raise a stronger suspicion of infection, inflammation, pulmonary embolism, or cancer. The amount of pleural fluid matters too. Small effusions may cause no symptoms at all, while large ones can lead to marked breathlessness and chest pain.
Pleural effusions are common in everyday respiratory and thoracic practice. In Singapore, lung specialists like Neumark Lung & Chest Surgery Centre regularly manage pleural effusion in patients with heart failure, pneumonia and cancer. This local reality matters because quickly identifying the underlying cause helps specialists treat the right problem.
The main types of pleural effusion are transudative and exudative, and the difference helps guide treatment.
A transudative pleural effusion happens when pressure changes in blood vessels cause watery fluid to leak into the pleural space. The fluid accumulates within intact blood vessels, and the visceral and parietal pleura remain uninflamed. Common pleural effusion causes of this type include congestive heart failure, liver cirrhosis, kidney disease, peritoneal dialysis and low blood protein levels.
On the other hand, an exudative pleural effusion occurs when inflammation, infection, cancer or pleural disease increases the permeability of the visceral and parietal pleura, allowing protein-rich pleural fluid to accumulate.
This distinction matters because the underlying cause changes the treatment plan. Transudative effusions often improve when the underlying systemic problem is controlled. An exudative effusion usually requires further investigation and may require drainage, biopsy, or surgery.
Pleural effusion symptoms depend on the amount of pleural fluid, how quickly it develops, and the cause.
The most common symptoms of pleural effusion are shortness of breath, chest pain and a cough. Some patients describe a heavy feeling in the chest. Shortness of breath and chest pain together are characteristic presenting features of pleural effusion causing respiratory symptoms. If the pleural fluid accumulates slowly, symptoms of pleural effusion may remain mild until the fluid accumulation becomes substantial. If it builds up quickly, even a smaller pleural fluid buildup can feel dramatic.
The signs of pleural effusion on examination may include reduced breath sounds, dullness to percussion, and reduced chest movement on the affected side. Imaging is still needed to confirm the presence of pleural fluid and estimate its volume.
The symptoms can also reflect the underlying cause. Fever, chills, and feeling unwell may point towards an infection. Weight loss or recurrent pleural fluid accumulation may suggest malignancy. Swollen legs and shortness of breath when lying flat may be more consistent with heart failure. This is why pleural effusion should never be treated as just a fluid problem. The pleural fluid is only part of the story; the underlying cause needs to be addressed.
Many pleural effusions are first assessed by a general physician, a respiratory specialist or an emergency doctor. Thoracic surgical input becomes especially important when pleural fluid keeps returning, is loculated, has progressed to empyema (a more advanced form of pleural effusion), the lung is trapped by scarring, or there is concern for cancer requiring biopsy or pleural procedures. Patients developing pleural effusion linked to cancer or a persistent infection should be assessed promptly to diagnose pleural effusion accurately, so that procedures can be planned appropriately.
A thoracic surgeon is also often involved when a less invasive management is no longer enough. This includes pleural effusions that do not resolve after drainage, recurrent malignant effusions, persistent pleural infection, or effusions in which the underlying diagnosis remains uncertain despite pleural fluid analysis.
This specialist review does not always lead to surgery. Sometimes it leads to a more structured drainage plan, pleurodesis, or pleural biopsy. The value lies in recognising which patients may benefit from a procedural solution before complications develop.
Diagnosis of pleural effusion begins with imaging and often requires pleural fluid analysis to identify the cause.
A medical history review and careful blood tests are essential early steps. Blood tests can reveal heart failure, kidney disease, or autoimmune conditions. Medical history often guides further pleural fluid analysis.
A chest X-ray is often the first clue. It may show blunting of the costophrenic angle, which is the anatomical junction where the chest wall meets the diaphragm, a meniscus of fluid, or a more extensive white-out if the effusion is large. An ultrasound scan is more sensitive than an X-ray for detecting smaller collections and is useful for safely guiding the drainage. Computed tomography (CT) scanning is especially helpful when the pleural fluid is complex, malignancy is suspected, or pleural thickening, loculations, trapped lung, or other thoracic conditions need to be assessed. CT scans also help identify blood clots and blood vessels affected by the disease process.
A key part of pleural effusion diagnosis is thoracentesis, also called a pleural tap. This involves using a needle to remove the pleural fluid for analysis. The pleural fluid is tested for protein, lactate dehydrogenase, pH, glucose, cell count, microbiology, and, where appropriate, pleural fluid cytology. Pleural fluid analysis and pleural fluid cytology together help determine whether the pleural fluid is transudative or exudative and narrow the list of causes of pleural effusion. Pleural fluid drainage during thoracentesis can also provide immediate symptom relief.
Some patients need more than a pleural fluid analysis. If the pleural fluid recurs, if the pleural fluid cytology is negative but malignancy remains a concern, or if the infection appears organised, doctors may recommend a pleural biopsy or thoracoscopy. The results of these biopsies are essential to guide further management.
The cause-based assessment is critical. Common causes of pleural effusion include heart failure, pneumonia, tuberculosis, pulmonary embolism, kidney disease, liver disease, autoimmune disease, chest trauma, and cancer. Causes of pleural effusion also include oesophageal rupture and lung disease. Pleural effusion risk factors, therefore, include chronic heart or kidney disease, cirrhosis, lung infections, previous cancer, smoking, thoracic surgery, chest injury, and known pleural or lung disease.
Pleural effusion treatment without surgery focuses on relieving the symptoms, treating the underlying cause, and, when possible, preventing the pleural fluid from returning.
The first step in managing pleural effusion is determining whether the excess fluid needs to be drained. A very small fluid buildup with a clear underlying cause may only need treatment of the underlying condition and monitoring. Pleural effusion treated through medical therapy alone can be effective when the cause is congestive heart failure or another systemic disease. For example, if heart failure is driving the fluid buildup, diuretics and an optimisation of cardiac care may allow the pleural fluid to settle without any procedure.
When pleural fluid is causing shortness of breath or other respiratory symptoms, or when the underlying cause needs further diagnosis, thoracentesis may be both therapeutic and diagnostic. This can improve breathing and shortness of breath while providing material for pleural fluid analysis. Pleural fluid drainage should be performed carefully to avoid reexpansion pulmonary oedema, a recognised complication when large volumes are removed too quickly.
For recurrent malignant effusions, one option is pleurodesis. This aims to make the visceral pleura adhere to the chest wall, so that excess fluid has no space to reaccumulate. Another option is an indwelling pleural catheter, which allows a repeated drainage of pleural fluid at home. In infection, antibiotics are essential, but drainage is often just as important. A chest tube may be needed when pleural fluid is heavily infected, thick, or loculated. Pulmonary oedema and vascular injury are potential risks during drainage. Your healthcare provider will discuss these risks with you before any procedures.
Good pleural effusion treatment is not only about removing pleural fluid. It is about choosing the least invasive method that still effectively treats the underlying cause.
Surgery is considered when pleural effusion is complex, recurrent, infected, trapped, or associated with pleural disease requiring direct treatment.
Video-Assisted Thoracoscopic Surgery (VATS) is often the preferred minimally invasive approach when pleural effusion needs more than simple drainage. Using small incisions and a camera, the surgeon can inspect the pleural cavity, obtain biopsies, break loculations, clear infected material from the pleural space, perform pleurodesis, and release trapped lung tissue due to scarring of the chest wall. VATS is especially valuable in infected pleural conditions, recurrent undiagnosed exudative effusions, and malignant pleural disease.
At Neumark, VATS plays an important role in managing pleural effusion when the pleural fluid is complex or recurrent. It can address several problems in a single sitting, offering a major advantage over repeated blind drainage.
An open approach, though rarer, may be needed when the empyema is very advanced, when a dense pleural peel requires formal decortication, when minimally invasive access is not safe enough, or when the underlying pleural or lung disease is more extensive than expected.
Thoracotomy is more invasive, but in selected cases, it is the best route to fully clear an infection or free a lung that has become trapped against the chest wall.
The choice between VATS and thoracotomy depends on the stage of disease, the extent of pleural organisation, the patient’s overall health, and the surgeon’s judgement about which approach will most effectively resolve the problem.
Recovery after treatment for a pleural effusion depends on the underlying cause, the procedure used, and whether the lung re-expands well.
After simple thoracentesis or pleural tap, recovery is usually quick, although continuous monitoring is needed to ensure there is no bleeding, blood clot formation, infection, or procedure-related pneumothorax. After chest tube drainage, a hospital stay may be necessary because the chest tube remains in place until the pleural fluid drainage has decreased and the lung is well expanded.
After a VATS or thoracotomy, recovery takes longer but is often very worthwhile when the underlying cause is infection, trapped lung, or a recurrent symptomatic pleural fluid. Risks of intervention can include bleeding from blood vessels, chest pain, infection, an air leak, a recurrence of excess fluid, an incomplete drainage, and an injury to nearby structures. In frail patients, the underlying illness may pose a greater risk than the procedure itself.
The main pleural effusion complications come from delayed treatment or an untreated underlying disease. These include trapped lung, empyema, sepsis, persistent breathlessness, reduced lung expansion, recurrent hospital admissions, and, in malignant cases, repeated symptomatic fluid re-accumulation. That is why recurring or complex effusions should not be drained repeatedly without a broader plan to address the root cause.
Many patients do recover well, especially when the underlying cause is reversible, and the pleural fluid is treated early. For some, especially those with chronic heart failure or cancer, the aim is longer-term control rather than permanent cure. Even then, a thoughtful treatment plan can greatly improve comfort and function in daily life.
Neumark Lung & Chest Surgery Centre helps by identifying the underlying cause of pleural effusion, choosing the right level of intervention, and offering minimally invasive thoracic surgery when needed.
Neumark specialises in pleural and thoracic conditions with a multidisciplinary approach led by Dr Harish Mithiran, senior consultant thoracic surgeon at Gleneagles and Mount Alvernia hospitals. That means looking beyond the pleural fluid itself and focusing on the full picture: why it is there, whether it is likely to recur, whether the lung is trapped, and whether a minimally invasive surgical approach could offer a more lasting solution for patients with pleural effusion.
When simple drainage is enough, we hope to avoid unnecessary procedures. When the pleural fluid is recurrent, loculated, or suspicious for malignancy, Neumark can assess whether VATS, pleural biopsy, pleurodesis, or decortication is more appropriate.
If you have been told you have pleural effusion, or if shortness of breath, chest pain, or recurrent pleural fluid around the lung is affecting your quality of life, contact Neumark Lung & Chest Surgery Centre for a consultation.
Pleural effusion can be mild or serious depending on the amount of fluid, how quickly it develops, and the cause. A small effusion may be manageable, but a large or infected effusion can become dangerous.
Yes, many patients recover, especially when the cause is identified early and treated properly. Recovery depends on the underlying disease and on whether the fluid returns.
Treatment may include observation, medications for the underlying cause, thoracentesis, chest tube drainage, pleurodesis, placement of an indwelling pleural catheter, or surgery such as VATS or thoracotomy.
Yes, many patients can, especially if the cause is treatable and the fluid is managed effectively. Long-term outlook depends more on the underlying condition than on the pleural effusion itself.
It can contribute to life-threatening deterioration if it is very large, rapidly progressive, heavily infected, or linked to a serious underlying illness. Sudden severe breathlessness should always be assessed urgently.
DISCLAIMER: The information provided on this website is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. The use of this website does not create a doctor-patient relationship and no medical advice should be inferred or assumed. It is the user’s sole responsibility to seek the advice of their healthcare professionals for any medical concerns they may have and the user should not disregard, or delay, prompt medical advice for any such condition.
Neumark Lung & Chest Surgery Centre benefits from the expertise of a multidisciplinary team led by Dr Harish Mithiran, senior consulting thoracic surgeon at Gleneagles Hospital and Mt Alvernia Hospital.
Neumark is a lung and chest specialist centre with access to leading treatment modalities to achieve the best possible outcomes for lung disease and preventative patient screening.
Our foremost priority is to treat your condition as effectively as possible. Schedule a private consultation today; complete the form below, call, +65 6908 2145; WhatsApp, +65 9726 2485; or email, info@neumarksurgery.com.
Gleneagles Medical Centre
6 Napier Road
#02-09 Gleneagles Medical Centre
Singapore 258499
Mount Alvernia Hospital
820 Thomson Road
#06-07 Medical Centre A
Singapore 574623
